Publication Name	World Journal of Diabetes
Manuscript ID	94401
Country	India

Received	2024-03-18 08:06
Peer-Review Started	2024-03-18 08:06
To Make the First Decision
Return for Revision	2024-05-02 20:29
Revised	2024-05-08 15:17
Second Decision	2024-05-24 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-05-24 07:48
Articles in Press	2024-05-24 07:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-31 08:40
Publish the Manuscript Online	2024-07-08 07:49

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Letter to the Editor
Article Title	Serum tumor markers: Can they clinically implicate in type 2 diabetes mellitus?
Manuscript Source	Invited Manuscript
All Author List	Kotha Sugunakar Reddy, Ilakkiya Priya Pandiaraj, Archana Gaur and Sakthivadivel Varatharajan
Funding Agency and Grant Number
Corresponding Author	Sakthivadivel Varatharajan, MBBS, MD, Additional Professor, Department of General Medicine, All India Institute of Medical Sciences, Varatharajan Sakthivadivel, Hyderabad 508126, Telangana, India. vsakthivadivel28@gmail.com
Key Words	Cancer antigen 19-9; Cancer antigen 242; Carcinoembryonic antigen; Tumor markers; Type 2 diabetes mellitus
Core Tip	The study explores the correlation between tumor markers and type 2 diabetes mellitus (T2DM), focusing on cancer antigen 19-9, cancer antigen 242, and carcinoembryonic antigen, in poorly controlled T2DM patients with hemoglobin A1c levels exceeding 9%. While offering insights into their diagnostic accuracy, caution is advised against routine tumor marker testing due to challenges like availability and cost, and confounding factors like smoking and alcohol consumption. Meng and Shi’s study is significant, but further research is needed to clarify the role of tumor markers in diabetes management and beyond.
Publish Date	2024-07-08 07:49
Citation	<p>Reddy KS, Pandiaraj IP, Gaur A, Varatharajan S. Serum tumor markers: Can they clinically implicate in type 2 diabetes mellitus? <i>World J Diabetes</i> 2024; 15(7): 1648-1650</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i7/1648.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i7.1648

Full Article (PDF)	WJD-15-1648-with-cover.pdf
Manuscript File	94401_Auto_Edited-YJP.docx
Answering Reviewers	94401-answering-reviewers.pdf
Audio Core Tip	94401-audio.mp3
Conflict-of-Interest Disclosure Form	94401-conflict-of-interest-statement.pdf
Copyright License Agreement	94401-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	94401-non-native-speakers.pdf
Peer-review Report	94401-peer-reviews.pdf
Scientific Misconduct Check	94401-scientific-misconduct-check.png
Scientific Misconduct Check	94401-scientific-misconduct-check.png
Scientific Editor Work List	94401-scientific-editor-work-list.pdf
CrossCheck Report	94401-crosscheck-report.pdf